SHR-A1912 targets CD79b on B cells, is internalized, and releases a topoisomerase I inhibitor that blocks DNA replication and triggers apoptosis in CD79b-positive cells; DNA topoisomerase I is the intracellular enzyme target of the payload, not the surface cytotoxic target.